Publications by authors named "Nisha A Mohindra"

Claim this Profile
A
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve -Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial).
Xiuning Le, Jyoti D Patel, Elaine Shum, Christina Baik, Rachel E Sanborn, Nisha A Mohindra

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of patient-reported outcome dashboards within the electronic health record to support shared decision-making in serious chronic illness.
Laura M Perry, Nisha A Mohindra, Ava Coughlin, Katy Bedjeti, Cynthia Barnard

BMJ Open Qual· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion.
Kymberly D Watt, Stacey Rolak, David P Foley, Jennifer K Plichta, Sandhya Pruthi, Nisha A Mohindra

Transplantation· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.
John A Thompson, Bryan J Schneider, Julie Brahmer, Mohammad Abu Zaid, Amaka Achufusi, Nisha A Mohindra

J Natl Compr Canc Netw· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an electronic health record-integrated patient-reported outcome-based shared decision-making dashboard in oncology.
Nisha A Mohindra, Sofia F Garcia, Sheetal Kircher, Cynthia Barnard, Laura M Perry

JAMIA Open· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Next-Generation Sequencing Workflows on Outcomes in Advanced Lung Cancer: A Retrospective Analysis at One Academic Health System.
Chetan V Vakkalagadda, Danielle B Dressler, Zequn Sun, Joseph Fuchs, Yingzhe Liu, Nisha A Mohindra

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a Co-Design Strategy to Develop a Dashboard to Support Shared Decision Making in Advanced Cancer and Chronic Kidney Disease.
Victoria Morken, Laura M Perry, Ava Coughlin, Mary O'Connor, Ryan Chmiel, Nisha A Mohindra

J Clin Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing a Patient-Reported Outcome Dashboard in Oncology Telemedicine Encounters: Clinician and Patient Adoption and Acceptability.
Nisha A Mohindra, Ava Coughlin, Sheetal Kircher, Alesia O'Daniel, Cynthia Barnard

JCO Oncol Pract· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II Trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced Non-Small Cell Lung Cancer: Hoosier Cancer Research Network LUN13-175.
Ryan D Gentzler, Nisha A Mohindra, Shadia I Jalal, Karen L Reckamp, Richard D Hall

Oncologist· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
General population reference values for the Functional Assessment of Cancer Therapy-Lung and PROMIS-29.
Nisha A Mohindra, John Devin Peipert, Steven I Blum, James W Shaw, John R Penrod

Cancer Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing, Monitoring, and Managing Ototoxicity Related to Cisplatin: Proactive Rather Than Reactive Approaches Are Needed.
Nisha A Mohindra

JCO Oncol Pract· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Top advances in lung cancer, 2021.
Nisha A Mohindra, Jyoti D Patel

Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.
John A Thompson, Bryan J Schneider, Julie Brahmer, Amaka Achufusi, Philippe Armand, Nisha A Mohindra

J Natl Compr Canc Netw· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer.
Daniel R Principe, Lauren Chiec, Nisha A Mohindra, Hidayatullah G Munshi

Front Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Michael S Oh, Alex Guzner, Derek A Wainwright, Nisha A Mohindra, Young K Chae

Clin Lung Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial.
Laurie E Steffen McLouth, Fengmin Zhao, Taofeek K Owonikoko, Josephine L Feliciano, Nisha A Mohindra

Cancer Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic Thymoma Harboring a Deleterious BRCA2 Mutation Derives Durable Clinical Benefit from Olaparib.
Daniel R Principe, Suneel D Kamath, Hidayatullah G Munshi, Nisha A Mohindra

Oncologist· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.
John A Thompson, Bryan J Schneider, Julie Brahmer, Stephanie Andrews, Philippe Armand, Nisha A Mohindra

J Natl Compr Canc Netw· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alveolar soft part sarcoma mimics prostate cancer metastasis.
Daniel R Principe, Nisha A Mohindra, Hidayatullah G Munshi, Suneel D Kamath

Oxf Med Case Reports· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials.
Saba S Shaikh, Priya U Kumthekar, Nisha A Mohindra

J Neurooncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-centered engagement and symptom/toxicity monitoring in the new era of tumor next-generation sequencing and immunotherapy: The OncoTool and OncoPRO platforms.
Betina Yanez, Laura C Bouchard, David Cella, Jeffrey A Sosman, Sheetal M Kircher, Nisha A Mohindra

Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Immunotherapy-Related Toxicities, Version 1.2019.
John A Thompson, Bryan J Schneider, Julie Brahmer, Stephanie Andrews, Philippe Armand, Nisha A Mohindra

J Natl Compr Canc Netw· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial Response to Anti-Programmed Death 1 Therapy in a Patient with Metastatic Non-Small Cell Lung Cancer with Leptomeningeal Carcinomatosis.
Suneel D Kamath, Priya U Kumthekar, Tim J Kruser, Nisha A Mohindra

Oncologist· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Low-Frequency Driver Mutations Detected by Cell-Free Circulating Tumor DNA to Guide Targeted Therapy in Non-Small-Cell Lung Cancer: A Multicenter Case Series.
Miriam T Jacobs, Nisha A Mohindra, Lindsey Shantzer, Ingrid L Chen, Hardeep Phull

JCO Precis Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers for PD-1/PD-L1 Blockade Therapy in Non-Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?
Young Kwang Chae, Alan Pan, Andrew A Davis, Kirtee Raparia, Nisha A Mohindra

Clin Lung Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis